We are currently upgrading the website. Please contact us with any issues! Thanks.

RESEARCH UPDATE:JSAT article explores incentives
in justice settings, co-authored by IRETA director

Click to read

JSAT article explores incentives
in justice settings, co-authored by IRETA director

CONFERENCE:2012 National Prevention
Network Conference

Read More

2012 National Prevention
Network Conference

NEW ATTC WEB RESOURCE:HIV Rapid Testing in
Substance Abuse Treatment Programs

Learn more

HIV Rapid Testing in
Substance Abuse Treatment Programs

Mission Statement

The Institute for Research, Education, and Training in Addictions (IRETA) is a 501 (c) (3) organization that works with national, state, and local partners to improve recognition, prevention, treatment, research and policy related to addiction and recovery.

To achieve its mission, IRETA will provide:

  • Accurate and timely dissemination of evidence-based information.
  • Bidirectional exchange of constructive knowledge related to addiction and recovery.
  • Knowledge of addiction and recovery in a culturally competent manner.

Learn more about IRETA

IRETA Director Peter Luongo was recognized as one of fifty "Heroes for Justice" on April 28 at the University of Maryland School of Social Work in Baltimore, MD as someone who has elevated the reputation and visibility of the social work profession.

Click here to read more: Archive

Conference materials for the February 9, 2012 conference, "Management of Benzodiazepines in Medication-Assisted Treatment" are now available for download. See slideshows from the foremost experts in the field and learn about next steps in the process.

Click here to read more: Archive

Community Care Behavioral Health has released the report "Best Practices in the Use of Buprenorphine" which describes a project conducted by IRETA during 2011 to develop a set of clinical guidelines for buprenorphine treatment as a resource for clinicians and payers.

Click here to read more: Archive
Spotlight archives »

IRETA CurrentE-newsletter

SUBSCRIBE

Facebook Twitter